Published on 11 Feb 2024 on Simply Wall St. via Yahoo Finance
Key Insights
Using the 2 Stage Free Cash Flow to Equity, Vera Therapeutics fair value estimate is US$46.59Vera Therapeutics' US$43.21 share price indicates it is trading at similar levels as its fair value estimate Analyst price target for VERA is US$32.11 which is 31% below our fair value estimate
Does the February share price for Vera Therapeutics, Inc. (NASDAQ:VERA) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting them to today's value. This will be done using the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple!